Cleared Traditional

VK100 Percutaneous Vertebral Augmentation System (K192403) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K192403 · Bonwrx, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2019
Decision
66d
Days
Class 2
Risk

K192403 is an FDA 510(k) clearance for the VK100 Percutaneous Vertebral Augmentation System. Classified as Cement, Bone, Vertebroplasty (product code NDN), Class II - Special Controls.

Submitted by Bonwrx, Ltd. (Lansing, US). The FDA issued a Cleared decision on November 8, 2019 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bonwrx, Ltd. devices

Submission Details

510(k) Number K192403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2019
Decision Date November 08, 2019
Days to Decision 66 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 122d · This submission: 66d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NDN Cement, Bone, Vertebroplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Msquared Associates, Inc.
Connie Qiu

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NDN Cement, Bone, Vertebroplasty

All 107
Devices cleared under the same product code (NDN) and FDA review panel - the closest regulatory comparables to K192403.
XeliteMed SuperM-Fix Spinal Bone Cement
K251896 · Xelite Biomed , Ltd. · Jan 2026
VCFix Spinal System
K250637 · Amber Implants · May 2025
XeliteMed VertehighFix High Viscosity Spinal Bone Cement System
K243537 · Xelite Biomed , Ltd. · Apr 2025
XeliteMed VertehighFix High Viscosity Spinal Bone Cement
K241775 · Xelite Biomed , Ltd. · Sep 2024
Balloon Inflation System
K232842 · Ningbo Hicren Biotechnology Co., Ltd. · Feb 2024
V-STRUT® Vertebral Implant
K240084 · Hyprevention · Feb 2024